11th Annual ECD Medical Symposium Birmingham, AL

Gaurav Goyal, MD
University of Alabama at Birmingham
Birmingham, Alabama US
May 1, 2026

Birmingham Medical Symposium Group Picture 2026

Symposium Summary

Approximately 44 medical professionals from 6 countries attended the Annual ECD Medical Symposium in 2026. 15 oral abstracts were presented, along with an additional 9 poster presentations. The keynote speaker, Nicole Coufal, MD, PhD, delivered a talk titled “Diversity and Degeneration in Neurohistiocytic Disease.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.

Programs with Symposium Agenda

Agenda

PresenterPresentation SlidesEnglish Video
Gaurav Goyal, MDView SlideWelcome to Birmingham and the 11th Annual Erdheim-Chester Disease International Conference
Nicole Coufal, MD (Keynote Speaker)View SlideDiversity and Degeneration in Neurohistiocytic Disease
Benjamin Durham, MDView SlideARAF Mutations Drive Histiocytic Neoplasms In Vivo and Provide Insights into Cellular Origin
Florian Houdu, MDView SlideTracking BRAF V600E Persistence under MEK Inhibition in Histiocytoses: a B-cell–enriched signal
Irena Ungureanu, MDView SlideDistribution of MAP2K1 Variants Across Peripheral Blood Cells in Erdheim-Chester Disease and Other Histiocytoses
Matthew Collin, MDView SlideThe Clonal Origin and Evolution of High-Risk Multisystem Histiocytosis in Adults
Dongni Yi, MDView SlideKRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition
Dongni Yi, MDView SlideCyclin D1 Overexpression Drives Replication Stress and Creates Therapeutic Vulnerabilities in Histiocytic Neoplasms
Jérôme Razanamahery, MDView SlideClonal Hematopoiesis Predicts Response to Interferon-α in Erdheim-Chester Disease and Myeloproliferative Neoplasms
Félicien Triboulet, MDView SlideImpact of Additional Genetic Variants in the Course of Erdheim-Chester Disease… a Multicentric Longitudinal Study of 445 French Patients
Guneet Janda, MDView SlidePatterns of Presentation and Outcomes in Adults Xanthogranulomas
Mustafa Abomohsen, MDView SlideNot available
Carla Isabel Borre, MDView SlideReal World Frontline Systemic Anti-Cancer Treatment Patterns and Outcomes in Erdheim–Chester Disease
Gaurav Goyal, MDView SlideBurden of Chronic Health Conditions After Diagnosis of Erdheim–Chester Disease (ECD): Early Results from the Histiocytic Disorder Survivor Study
Julien Haroche, MD, PhDView SlideDestombes-Rosai-Dorfman Disease: Clinical, Molecular Characteristics and Treatment Response: data from a retrospective cohort of 107 patients
Anneka Johnston, MDView SlideConsiderations for Assessment and Treatment of Neuropsychiatric Symptoms in ECD
Matthew Collin, MD, PhDView SlideAll that glitters: retro-orbital xanthogranuloma or ECD?
Jithma Abeykoon, MDView SlideThe Clue Was the Blood Pressure: Atypical Erdheim–Chester Disease
Jerome HensonECD Global Alliance into the FutureECD Global Alliance into the Future

Photographs

Celebration Dinner

Medical Symposium

Medical Reception

Care Center Meeting